Pictet Asset Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$993K Sell
2,132
-173
-8% -$72.7K ﹤0.01% 1153
2026
Q1
$871K Buy
2,305
+110
+5% +$47.1K ﹤0.01% 1177
2025
Q4
$939K Buy
2,195
+114
+5% +$49.6K ﹤0.01% 1130
2025
Q3
$932K Hold
2,081
– – ﹤0.01% 1092
2025
Q2
$1.01M Sell
2,081
-12,902
-86% -$7.35M ﹤0.01% 1049
2025
Q1
$9.22M Sell
14,983
-14,558
-49% -$8.27M 0.01% 681
2024
Q4
$15.7M Sell
29,541
-9,330
-24% -$5.26M 0.02% 564
2024
Q3
$23.4M Buy
38,871
+852
+2% +$483K 0.03% 449
2024
Q2
$20.6M Buy
38,019
+673
+2% +$385K 0.02% 458
2024
Q1
$24M Sell
37,346
-15,832
-30% -$9.62M 0.03% 461
2023
Q4
$31.1M Sell
53,178
-25,803
-33% -$14.4M 0.03% 384
2023
Q3
$41M Buy
+78,981
New +$41.1M 0.05% 321

Other funds holding CHE

Pictet Asset Management's CHE Position: Q2 2026 in Review

Pictet Asset Management reduced its Chemed (CHE) stake by 7.5% in Q2 2026, selling an estimated $72.7K and leaving 2,132 shares worth $993K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Pictet Asset Management first reported a position in CHE in Q3 2023 and has held it in 12 quarters since. The position peaked at $41M in Q3 2023. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Pictet Asset Management held 2,132 shares of Chemed worth $993K as of Q2 2026.
  • Pictet Asset Management sold 173 Chemed shares in Q2 2026, an estimated $72.7K.
  • Chemed made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1153 holding.
  • Pictet Asset Management first reported a position in Chemed in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Chemed position peaked at $41M in Q3 2023.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.